S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NASDAQ:OPK

OPKO Health (OPK) Stock Forecast, Price & News

$1.45
+0.05 (+3.57%)
(As of 06/2/2023 ET)
Compare
Today's Range
$1.40
$1.47
50-Day Range
$1.32
$1.86
52-Week Range
$1.00
$3.07
Volume
3.10 million shs
Average Volume
2.36 million shs
Market Capitalization
$1.12 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.13

OPKO Health MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
185.1% Upside
$4.13 Price Target
Short Interest
Bearish
9.82% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.65
Upright™ Environmental Score
News Sentiment
0.35mentions of OPKO Health in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$1.78 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.28) to ($0.24) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

231st out of 983 stocks

Pharmaceutical Preparations Industry

104th out of 486 stocks


OPK stock logo

About OPKO Health (NASDAQ:OPK) Stock

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Receive OPK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter.

OPK Stock News Headlines

“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
OPKO Health (NASDAQ:OPK) Upgraded to "Hold" by StockNews.com
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
Gary Nabel Spends US$541k On OPKO Health Stock \
OPKO Health: There Could Be A Chance For Upside
Monday 5/8 Insider Buying Report: OPK, ZION
OPKO Health (NASDAQ:OPK) Price Target Cut to $5.40
OPKO Health (NASDAQ:OPK) Shares Up 8.5% on Strong Earnings
Barrington Reaffirms Their Hold Rating on Opko Health (OPK)
Q1 2023 OPKO Health Inc Earnings Call
Recap: OPKO Health Q1 Earnings
See More Headlines

OPK Price History

OPK Company Calendar

Last Earnings
5/03/2023
Today
6/04/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:OPK
CUSIP
68375N10
Employees
4,196
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.13
High Stock Price Forecast
$5.40
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+185.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-328,400,000.00
Pretax Margin
-36.37%

Debt

Sales & Book Value

Annual Sales
$912.55 million
Book Value
$2.01 per share

Miscellaneous

Free Float
456,096,000
Market Cap
$1.12 billion
Optionable
Optionable
Beta
1.66

Key Executives

  • Phillip Frost
    Chairman & Chief Executive Officer
  • Elias A. Zerhouni
    Vice Chairman & President
  • Adam E. Logal
    CFO, Treasurer, Chief Accounting Officer & SVP
  • Jane H. Hsaio
    Vice Chairman & Chief Technical Officer
  • Steven D. Rubin
    Director & Executive Vice President-Administration













OPK Stock - Frequently Asked Questions

Should I buy or sell OPKO Health stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OPKO Health in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OPK shares.
View OPK analyst ratings
or view top-rated stocks.

What is OPKO Health's stock price forecast for 2023?

2 analysts have issued 1-year price objectives for OPKO Health's shares. Their OPK share price forecasts range from $3.00 to $5.40. On average, they predict the company's stock price to reach $4.13 in the next year. This suggests a possible upside of 185.1% from the stock's current price.
View analysts price targets for OPK
or view top-rated stocks among Wall Street analysts.

How have OPK shares performed in 2023?

OPKO Health's stock was trading at $1.25 at the beginning of 2023. Since then, OPK shares have increased by 16.0% and is now trading at $1.45.
View the best growth stocks for 2023 here
.

When is OPKO Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our OPK earnings forecast
.

How were OPKO Health's earnings last quarter?

OPKO Health, Inc. (NASDAQ:OPK) issued its quarterly earnings data on Wednesday, May, 3rd. The biotechnology company reported ($0.02) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.05. The biotechnology company earned $237.60 million during the quarter, compared to analysts' expectations of $193.35 million. OPKO Health had a negative net margin of 31.92% and a negative trailing twelve-month return on equity of 13.63%. The company's revenue for the quarter was down 27.8% on a year-over-year basis. During the same period in the prior year, the business earned ($0.08) earnings per share.

What is Philip Frost's approval rating as OPKO Health's CEO?

21 employees have rated OPKO Health Chief Executive Officer Philip Frost on Glassdoor.com. Philip Frost has an approval rating of 16% among the company's employees. This puts Philip Frost in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OPKO Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OPKO Health investors own include TherapeuticsMD (TXMD), Micron Technology (MU), NVIDIA (NVDA), bluebird bio (BLUE), Gilead Sciences (GILD), Pfizer (PFE), Inovio Pharmaceuticals (INO), Novavax (NVAX), Advanced Micro Devices (AMD) and AT&T (T).

What is OPKO Health's stock symbol?

OPKO Health trades on the NASDAQ under the ticker symbol "OPK."

Who are OPKO Health's major shareholders?

OPKO Health's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (4.53%), State Street Corp (1.36%), Geode Capital Management LLC (1.09%), Dimensional Fund Advisors LP (0.89%), Charles Schwab Investment Management Inc. (0.63%) and Numerai GP LLC (0.29%). Insiders that own company stock include Elias A Zerhouni, Gary J Nabel, Jon R Cohen, Opko Health, Inc, Phillip Md Et Al Frost, Robert J Shovlin and Steven D Rubin.
View institutional ownership trends
.

How do I buy shares of OPKO Health?

Shares of OPK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OPKO Health's stock price today?

One share of OPK stock can currently be purchased for approximately $1.45.

How much money does OPKO Health make?

OPKO Health (NASDAQ:OPK) has a market capitalization of $1.12 billion and generates $912.55 million in revenue each year. The biotechnology company earns $-328,400,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis.

How many employees does OPKO Health have?

The company employs 4,196 workers across the globe.

How can I contact OPKO Health?

OPKO Health's mailing address is 4400 BISCAYNE BLVD., MIAMI FL, 33137. The official website for the company is www.opko.com. The biotechnology company can be reached via phone at (305) 575-4100, via email at mmiller@lhai.com, or via fax at 305-575-6015.

This page (NASDAQ:OPK) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -